世界の誘発性腟前庭痛治療薬市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Provoked Vestibulodynia Drug Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4782
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、96ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、誘発性腟前庭痛治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口薬、外用薬、注射薬）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・誘発性腟前庭痛治療薬の市場動向
・企業の競争状況、市場シェア
・誘発性腟前庭痛治療薬の種類別市場規模と予測2016-2027（経口薬、外用薬、注射薬）
・誘発性腟前庭痛治療薬の用途別市場規模と予測2016-2027（病院薬局、小売薬局、オンライン薬局）
・誘発性腟前庭痛治療薬の北米市場規模2016-2027（アメリカ、カナダ）
・誘発性腟前庭痛治療薬の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・誘発性腟前庭痛治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・誘発性腟前庭痛治療薬の中南米市場規模2016-2027（メキシコ、ブラジル）
・誘発性腟前庭痛治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（LGM Pharma、Pfizer、Fresenius、Bristol-Myers Squibb、Cadila Healthcare、Baxter、Teva、Mylan、Johnson & Johnson）
・結論

Provoked Vestibulodynia is chronic and distressing genital pain which is known as vestibule provoked by touch and sexual activity. Provoked vestibulodynia is most prevalent cause of pain during sexual activity in premenopausal women and insertion of a tampon or speculum which involves sensations of stinging, burning, irritation, and rawness in the area.

Market Analysis and Insights: Global Provoked Vestibulodynia Drug Market
The global Provoked Vestibulodynia Drug market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Provoked Vestibulodynia Drug market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Provoked Vestibulodynia Drug market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Provoked Vestibulodynia Drug market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Provoked Vestibulodynia Drug market.

Global Provoked Vestibulodynia Drug Scope and Market Size
Provoked Vestibulodynia Drug market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Provoked Vestibulodynia Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Oral Drug
Topical Drug
Injectable Drug

Segment by Application
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
LGM Pharma
Pfizer
Fresenius
Bristol-Myers Squibb
Cadila Healthcare
Baxter
Teva
Mylan
Johnson & Johnson

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Provoked Vestibulodynia Drug Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Oral Drug
1.2.3 Topical Drug
1.2.4 Injectable Drug
1.3 Market by Application
1.3.1 Global Provoked Vestibulodynia Drug Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Provoked Vestibulodynia Drug Market Perspective (2016-2027)
2.2 Provoked Vestibulodynia Drug Growth Trends by Regions
2.2.1 Provoked Vestibulodynia Drug Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Provoked Vestibulodynia Drug Historic Market Share by Regions (2016-2021)
2.2.3 Provoked Vestibulodynia Drug Forecasted Market Size by Regions (2022-2027)
2.3 Provoked Vestibulodynia Drug Industry Dynamic
2.3.1 Provoked Vestibulodynia Drug Market Trends
2.3.2 Provoked Vestibulodynia Drug Market Drivers
2.3.3 Provoked Vestibulodynia Drug Market Challenges
2.3.4 Provoked Vestibulodynia Drug Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Provoked Vestibulodynia Drug Players by Revenue
3.1.1 Global Top Provoked Vestibulodynia Drug Players by Revenue (2016-2021)
3.1.2 Global Provoked Vestibulodynia Drug Revenue Market Share by Players (2016-2021)
3.2 Global Provoked Vestibulodynia Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Provoked Vestibulodynia Drug Revenue
3.4 Global Provoked Vestibulodynia Drug Market Concentration Ratio
3.4.1 Global Provoked Vestibulodynia Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Provoked Vestibulodynia Drug Revenue in 2020
3.5 Provoked Vestibulodynia Drug Key Players Head office and Area Served
3.6 Key Players Provoked Vestibulodynia Drug Product Solution and Service
3.7 Date of Enter into Provoked Vestibulodynia Drug Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Provoked Vestibulodynia Drug Breakdown Data by Type
4.1 Global Provoked Vestibulodynia Drug Historic Market Size by Type (2016-2021)
4.2 Global Provoked Vestibulodynia Drug Forecasted Market Size by Type (2022-2027)

5 Provoked Vestibulodynia Drug Breakdown Data by Application
5.1 Global Provoked Vestibulodynia Drug Historic Market Size by Application (2016-2021)
5.2 Global Provoked Vestibulodynia Drug Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Provoked Vestibulodynia Drug Market Size (2016-2027)
6.2 North America Provoked Vestibulodynia Drug Market Size by Type
6.2.1 North America Provoked Vestibulodynia Drug Market Size by Type (2016-2021)
6.2.2 North America Provoked Vestibulodynia Drug Market Size by Type (2022-2027)
6.2.3 North America Provoked Vestibulodynia Drug Market Size by Type (2016-2027)
6.3 North America Provoked Vestibulodynia Drug Market Size by Application
6.3.1 North America Provoked Vestibulodynia Drug Market Size by Application (2016-2021)
6.3.2 North America Provoked Vestibulodynia Drug Market Size by Application (2022-2027)
6.3.3 North America Provoked Vestibulodynia Drug Market Size by Application (2016-2027)
6.4 North America Provoked Vestibulodynia Drug Market Size by Country
6.4.1 North America Provoked Vestibulodynia Drug Market Size by Country (2016-2021)
6.4.2 North America Provoked Vestibulodynia Drug Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Provoked Vestibulodynia Drug Market Size (2016-2027)
7.2 Europe Provoked Vestibulodynia Drug Market Size by Type
7.2.1 Europe Provoked Vestibulodynia Drug Market Size by Type (2016-2021)
7.2.2 Europe Provoked Vestibulodynia Drug Market Size by Type (2022-2027)
7.2.3 Europe Provoked Vestibulodynia Drug Market Size by Type (2016-2027)
7.3 Europe Provoked Vestibulodynia Drug Market Size by Application
7.3.1 Europe Provoked Vestibulodynia Drug Market Size by Application (2016-2021)
7.3.2 Europe Provoked Vestibulodynia Drug Market Size by Application (2022-2027)
7.3.3 Europe Provoked Vestibulodynia Drug Market Size by Application (2016-2027)
7.4 Europe Provoked Vestibulodynia Drug Market Size by Country
7.4.1 Europe Provoked Vestibulodynia Drug Market Size by Country (2016-2021)
7.4.2 Europe Provoked Vestibulodynia Drug Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Provoked Vestibulodynia Drug Market Size (2016-2027)
8.2 Asia-Pacific Provoked Vestibulodynia Drug Market Size by Type
8.2.1 Asia-Pacific Provoked Vestibulodynia Drug Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Provoked Vestibulodynia Drug Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Provoked Vestibulodynia Drug Market Size by Type (2016-2027)
8.3 Asia-Pacific Provoked Vestibulodynia Drug Market Size by Application
8.3.1 Asia-Pacific Provoked Vestibulodynia Drug Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Provoked Vestibulodynia Drug Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Provoked Vestibulodynia Drug Market Size by Application (2016-2027)
8.4 Asia-Pacific Provoked Vestibulodynia Drug Market Size by Region
8.4.1 Asia-Pacific Provoked Vestibulodynia Drug Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Provoked Vestibulodynia Drug Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Provoked Vestibulodynia Drug Market Size (2016-2027)
9.2 Latin America Provoked Vestibulodynia Drug Market Size by Type
9.2.1 Latin America Provoked Vestibulodynia Drug Market Size by Type (2016-2021)
9.2.2 Latin America Provoked Vestibulodynia Drug Market Size by Type (2022-2027)
9.2.3 Latin America Provoked Vestibulodynia Drug Market Size by Type (2016-2027)
9.3 Latin America Provoked Vestibulodynia Drug Market Size by Application
9.3.1 Latin America Provoked Vestibulodynia Drug Market Size by Application (2016-2021)
9.3.2 Latin America Provoked Vestibulodynia Drug Market Size by Application (2022-2027)
9.3.3 Latin America Provoked Vestibulodynia Drug Market Size by Application (2016-2027)
9.4 Latin America Provoked Vestibulodynia Drug Market Size by Country
9.4.1 Latin America Provoked Vestibulodynia Drug Market Size by Country (2016-2021)
9.4.2 Latin America Provoked Vestibulodynia Drug Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Provoked Vestibulodynia Drug Market Size (2016-2027)
10.2 Middle East & Africa Provoked Vestibulodynia Drug Market Size by Type
10.2.1 Middle East & Africa Provoked Vestibulodynia Drug Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Provoked Vestibulodynia Drug Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Provoked Vestibulodynia Drug Market Size by Type (2016-2027)
10.3 Middle East & Africa Provoked Vestibulodynia Drug Market Size by Application
10.3.1 Middle East & Africa Provoked Vestibulodynia Drug Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Provoked Vestibulodynia Drug Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Provoked Vestibulodynia Drug Market Size by Application (2016-2027)
10.4 Middle East & Africa Provoked Vestibulodynia Drug Market Size by Country
10.4.1 Middle East & Africa Provoked Vestibulodynia Drug Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Provoked Vestibulodynia Drug Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 LGM Pharma
11.1.1 LGM Pharma Company Details
11.1.2 LGM Pharma Business Overview
11.1.3 LGM Pharma Provoked Vestibulodynia Drug Introduction
11.1.4 LGM Pharma Revenue in Provoked Vestibulodynia Drug Business (2016-2021)
11.1.5 LGM Pharma Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Provoked Vestibulodynia Drug Introduction
11.2.4 Pfizer Revenue in Provoked Vestibulodynia Drug Business (2016-2021)
11.2.5 Pfizer Recent Development
11.3 Fresenius
11.3.1 Fresenius Company Details
11.3.2 Fresenius Business Overview
11.3.3 Fresenius Provoked Vestibulodynia Drug Introduction
11.3.4 Fresenius Revenue in Provoked Vestibulodynia Drug Business (2016-2021)
11.3.5 Fresenius Recent Development
11.4 Bristol-Myers Squibb
11.4.1 Bristol-Myers Squibb Company Details
11.4.2 Bristol-Myers Squibb Business Overview
11.4.3 Bristol-Myers Squibb Provoked Vestibulodynia Drug Introduction
11.4.4 Bristol-Myers Squibb Revenue in Provoked Vestibulodynia Drug Business (2016-2021)
11.4.5 Bristol-Myers Squibb Recent Development
11.5 Cadila Healthcare
11.5.1 Cadila Healthcare Company Details
11.5.2 Cadila Healthcare Business Overview
11.5.3 Cadila Healthcare Provoked Vestibulodynia Drug Introduction
11.5.4 Cadila Healthcare Revenue in Provoked Vestibulodynia Drug Business (2016-2021)
11.5.5 Cadila Healthcare Recent Development
11.6 Baxter
11.6.1 Baxter Company Details
11.6.2 Baxter Business Overview
11.6.3 Baxter Provoked Vestibulodynia Drug Introduction
11.6.4 Baxter Revenue in Provoked Vestibulodynia Drug Business (2016-2021)
11.6.5 Baxter Recent Development
11.7 Teva
11.7.1 Teva Company Details
11.7.2 Teva Business Overview
11.7.3 Teva Provoked Vestibulodynia Drug Introduction
11.7.4 Teva Revenue in Provoked Vestibulodynia Drug Business (2016-2021)
11.7.5 Teva Recent Development
11.8 Mylan
11.8.1 Mylan Company Details
11.8.2 Mylan Business Overview
11.8.3 Mylan Provoked Vestibulodynia Drug Introduction
11.8.4 Mylan Revenue in Provoked Vestibulodynia Drug Business (2016-2021)
11.8.5 Mylan Recent Development
11.9 Johnson & Johnson
11.9.1 Johnson & Johnson Company Details
11.9.2 Johnson & Johnson Business Overview
11.9.3 Johnson & Johnson Provoked Vestibulodynia Drug Introduction
11.9.4 Johnson & Johnson Revenue in Provoked Vestibulodynia Drug Business (2016-2021)
11.9.5 Johnson & Johnson Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Provoked Vestibulodynia Drug Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Oral Drug
Table 3. Key Players of Topical Drug
Table 4. Key Players of Injectable Drug
Table 5. Global Provoked Vestibulodynia Drug Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Provoked Vestibulodynia Drug Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Provoked Vestibulodynia Drug Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Provoked Vestibulodynia Drug Market Share by Regions (2016-2021)
Table 9. Global Provoked Vestibulodynia Drug Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Provoked Vestibulodynia Drug Market Share by Regions (2022-2027)
Table 11. Provoked Vestibulodynia Drug Market Trends
Table 12. Provoked Vestibulodynia Drug Market Drivers
Table 13. Provoked Vestibulodynia Drug Market Challenges
Table 14. Provoked Vestibulodynia Drug Market Restraints
Table 15. Global Provoked Vestibulodynia Drug Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Provoked Vestibulodynia Drug Market Share by Players (2016-2021)
Table 17. Global Top Provoked Vestibulodynia Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Provoked Vestibulodynia Drug as of 2020)
Table 18. Ranking of Global Top Provoked Vestibulodynia Drug Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Provoked Vestibulodynia Drug Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Provoked Vestibulodynia Drug Product Solution and Service
Table 22. Date of Enter into Provoked Vestibulodynia Drug Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Provoked Vestibulodynia Drug Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Provoked Vestibulodynia Drug Revenue Market Share by Type (2016-2021)
Table 26. Global Provoked Vestibulodynia Drug Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Provoked Vestibulodynia Drug Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Provoked Vestibulodynia Drug Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Provoked Vestibulodynia Drug Revenue Market Share by Application (2016-2021)
Table 30. Global Provoked Vestibulodynia Drug Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Provoked Vestibulodynia Drug Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Provoked Vestibulodynia Drug Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Provoked Vestibulodynia Drug Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Provoked Vestibulodynia Drug Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Provoked Vestibulodynia Drug Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Provoked Vestibulodynia Drug Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Provoked Vestibulodynia Drug Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Provoked Vestibulodynia Drug Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Provoked Vestibulodynia Drug Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Provoked Vestibulodynia Drug Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Provoked Vestibulodynia Drug Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Provoked Vestibulodynia Drug Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Provoked Vestibulodynia Drug Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Provoked Vestibulodynia Drug Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Provoked Vestibulodynia Drug Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Provoked Vestibulodynia Drug Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Provoked Vestibulodynia Drug Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Provoked Vestibulodynia Drug Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Provoked Vestibulodynia Drug Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Provoked Vestibulodynia Drug Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Provoked Vestibulodynia Drug Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Provoked Vestibulodynia Drug Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Provoked Vestibulodynia Drug Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Provoked Vestibulodynia Drug Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Provoked Vestibulodynia Drug Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Provoked Vestibulodynia Drug Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Provoked Vestibulodynia Drug Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Provoked Vestibulodynia Drug Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Provoked Vestibulodynia Drug Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Provoked Vestibulodynia Drug Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Provoked Vestibulodynia Drug Market Size by Country (2022-2027) & (US$ Million)
Table 62. LGM Pharma Company Details
Table 63. LGM Pharma Business Overview
Table 64. LGM Pharma Provoked Vestibulodynia Drug Product
Table 65. LGM Pharma Revenue in Provoked Vestibulodynia Drug Business (2016-2021) & (US$ Million)
Table 66. LGM Pharma Recent Development
Table 67. Pfizer Company Details
Table 68. Pfizer Business Overview
Table 69. Pfizer Provoked Vestibulodynia Drug Product
Table 70. Pfizer Revenue in Provoked Vestibulodynia Drug Business (2016-2021) & (US$ Million)
Table 71. Pfizer Recent Development
Table 72. Fresenius Company Details
Table 73. Fresenius Business Overview
Table 74. Fresenius Provoked Vestibulodynia Drug Product
Table 75. Fresenius Revenue in Provoked Vestibulodynia Drug Business (2016-2021) & (US$ Million)
Table 76. Fresenius Recent Development
Table 77. Bristol-Myers Squibb Company Details
Table 78. Bristol-Myers Squibb Business Overview
Table 79. Bristol-Myers Squibb Provoked Vestibulodynia Drug Product
Table 80. Bristol-Myers Squibb Revenue in Provoked Vestibulodynia Drug Business (2016-2021) & (US$ Million)
Table 81. Bristol-Myers Squibb Recent Development
Table 82. Cadila Healthcare Company Details
Table 83. Cadila Healthcare Business Overview
Table 84. Cadila Healthcare Provoked Vestibulodynia Drug Product
Table 85. Cadila Healthcare Revenue in Provoked Vestibulodynia Drug Business (2016-2021) & (US$ Million)
Table 86. Cadila Healthcare Recent Development
Table 87. Baxter Company Details
Table 88. Baxter Business Overview
Table 89. Baxter Provoked Vestibulodynia Drug Product
Table 90. Baxter Revenue in Provoked Vestibulodynia Drug Business (2016-2021) & (US$ Million)
Table 91. Baxter Recent Development
Table 92. Teva Company Details
Table 93. Teva Business Overview
Table 94. Teva Provoked Vestibulodynia Drug Product
Table 95. Teva Revenue in Provoked Vestibulodynia Drug Business (2016-2021) & (US$ Million)
Table 96. Teva Recent Development
Table 97. Mylan Company Details
Table 98. Mylan Business Overview
Table 99. Mylan Revenue in Provoked Vestibulodynia Drug Business (2016-2021) & (US$ Million)
Table 100. Mylan Recent Development
Table 101. Johnson & Johnson Company Details
Table 102. Johnson & Johnson Business Overview
Table 103. Johnson & Johnson Provoked Vestibulodynia Drug Product
Table 104. Johnson & Johnson Revenue in Provoked Vestibulodynia Drug Business (2016-2021) & (US$ Million)
Table 105. Johnson & Johnson Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Provoked Vestibulodynia Drug Market Share by Type: 2020 VS 2027
Figure 2. Oral Drug Features
Figure 3. Topical Drug Features
Figure 4. Injectable Drug Features
Figure 5. Global Provoked Vestibulodynia Drug Market Share by Application: 2020 VS 2027
Figure 6. Hospital Pharmacy Case Studies
Figure 7. Retail Pharmacy Case Studies
Figure 8. Online Pharmacy Case Studies
Figure 9. Provoked Vestibulodynia Drug Report Years Considered
Figure 10. Global Provoked Vestibulodynia Drug Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Provoked Vestibulodynia Drug Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Provoked Vestibulodynia Drug Market Share by Regions: 2020 VS 2027
Figure 13. Global Provoked Vestibulodynia Drug Market Share by Regions (2022-2027)
Figure 14. Global Provoked Vestibulodynia Drug Market Share by Players in 2020
Figure 15. Global Top Provoked Vestibulodynia Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Provoked Vestibulodynia Drug as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Provoked Vestibulodynia Drug Revenue in 2020
Figure 17. Global Provoked Vestibulodynia Drug Revenue Market Share by Type (2016-2021)
Figure 18. Global Provoked Vestibulodynia Drug Revenue Market Share by Type (2022-2027)
Figure 19. North America Provoked Vestibulodynia Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Provoked Vestibulodynia Drug Market Share by Type (2016-2027)
Figure 21. North America Provoked Vestibulodynia Drug Market Share by Application (2016-2027)
Figure 22. North America Provoked Vestibulodynia Drug Market Share by Country (2016-2027)
Figure 23. United States Provoked Vestibulodynia Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Provoked Vestibulodynia Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Provoked Vestibulodynia Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Provoked Vestibulodynia Drug Market Share by Type (2016-2027)
Figure 27. Europe Provoked Vestibulodynia Drug Market Share by Application (2016-2027)
Figure 28. Europe Provoked Vestibulodynia Drug Market Share by Country (2016-2027)
Figure 29. Germany Provoked Vestibulodynia Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Provoked Vestibulodynia Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Provoked Vestibulodynia Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Provoked Vestibulodynia Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Provoked Vestibulodynia Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Provoked Vestibulodynia Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Provoked Vestibulodynia Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Provoked Vestibulodynia Drug Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Provoked Vestibulodynia Drug Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Provoked Vestibulodynia Drug Market Share by Region (2016-2027)
Figure 39. China Provoked Vestibulodynia Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Provoked Vestibulodynia Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Provoked Vestibulodynia Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Provoked Vestibulodynia Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Provoked Vestibulodynia Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Provoked Vestibulodynia Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Provoked Vestibulodynia Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Provoked Vestibulodynia Drug Market Share by Type (2016-2027)
Figure 47. Latin America Provoked Vestibulodynia Drug Market Share by Application (2016-2027)
Figure 48. Latin America Provoked Vestibulodynia Drug Market Share by Country (2016-2027)
Figure 49. Mexico Provoked Vestibulodynia Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Provoked Vestibulodynia Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Provoked Vestibulodynia Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Provoked Vestibulodynia Drug Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Provoked Vestibulodynia Drug Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Provoked Vestibulodynia Drug Market Share by Country (2016-2027)
Figure 55. Turkey Provoked Vestibulodynia Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Provoked Vestibulodynia Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Provoked Vestibulodynia Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. LGM Pharma Revenue Growth Rate in Provoked Vestibulodynia Drug Business (2016-2021)
Figure 59. Pfizer Revenue Growth Rate in Provoked Vestibulodynia Drug Business (2016-2021)
Figure 60. Fresenius Revenue Growth Rate in Provoked Vestibulodynia Drug Business (2016-2021)
Figure 61. Bristol-Myers Squibb Revenue Growth Rate in Provoked Vestibulodynia Drug Business (2016-2021)
Figure 62. Cadila Healthcare Revenue Growth Rate in Provoked Vestibulodynia Drug Business (2016-2021)
Figure 63. Baxter Revenue Growth Rate in Provoked Vestibulodynia Drug Business (2016-2021)
Figure 64. Teva Revenue Growth Rate in Provoked Vestibulodynia Drug Business (2016-2021)
Figure 65. Mylan Revenue Growth Rate in Provoked Vestibulodynia Drug Business (2016-2021)
Figure 66. Johnson & Johnson Revenue Growth Rate in Provoked Vestibulodynia Drug Business (2016-2021)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed

以下、関連資料のご紹介

世界のスニチニブ薬市場規模・現状・予測（2021年-2027年）

Global Sunitinib Drug Market Size, Status and Forecast 2021-2027
QFJ1-6026 2021年6月 89Pages
QYResearch社発行の本調査レポートでは、スニチニブ薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（12.5mgカプセル、25mgカプセル、37.5mgカプセル、50mgカプセル）、用途別市場規模（腎臓がん、GIST、pNET）、主要地域別...

世界のアンブリセンタン薬市場規模・現状・予測（2021年-2027年）

Global Ambrisentan Drug Market Size, Status and Forecast 2021-2027
QFJ1-5574 2021年6月 87Pages
QYResearch社発行の本調査レポートでは、アンブリセンタン薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（5mg錠、10mg錠）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南...

世界の甲状腺機能低下症治療薬市場規模・現状・予測（2021年-2027年）

Global Hypothyroidism Drug Market Size, Status and Forecast 2021-2027
QFJ1-4342 2021年6月 87Pages
QYResearch社発行の本調査レポートでは、甲状腺機能低下症治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（BCT-305、GX-30、レボチロキシンナトリウムSR、リオチロニン、その他）、用途別市場規模（病院、診療所、その他）、主要地域...

世界の向精神薬市場規模・現状・予測（2021年-2027年）

Global Psychotropic Drug Market Size, Status and Forecast 2021-2027
QFJ1-4785 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、向精神薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（鎮痛薬、麻酔薬、催眠薬、その他）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、...

世界の抗コリン薬市場規模・現状・予測（2021年-2027年）

Global Anticholinergic Drug Market Size, Status and Forecast 2021-2027
QFJ1-5583 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、抗コリン薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口、非経口、局所）、用途別市場規模（病院薬局、小売薬局、オンライン薬局、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中...

世界のパルボシクリブ薬市場規模・現状・予測（2021年-2027年）

Global Palbociclib Drug Market Size, Status and Forecast 2021-2027
QFJ1-5925 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、パルボシクリブ薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（錠剤タイプパルボシクリブ薬、カプセルタイプパルボシクリブ薬）、用途別市場規模（病院、診断センター、研究所）、主要地域別市場規模（北米、ア...

世界のノイラミニダーゼ阻害薬市場規模・現状・予測（2021年-2027年）

Global Neuraminidase Inhibitors Drug Market Size, Status and Forecast 2021-2027
QFJ1-5878 2021年6月 86Pages
QYResearch社発行の本調査レポートでは、ノイラミニダーゼ阻害薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（オセルタミビル、ザナミビル、ペラミビル、ラニナミビル）、用途別市場規模（病院薬局、小売薬局、オンライン薬局、その他）、主要地域別市...

世界の急性肝性ポルフィリン症用医薬品市場規模・現状・予測（2021年-2027年）

Global Acute Hepatic Porphyria Drug Market Size, Status and Forecast 2021-2027
QFJ1-5564 2021年6月 89Pages
QYResearch社発行の本調査レポートでは、急性肝性ポルフィリン症用医薬品の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（350 Mg、313 Mg）、用途別市場規模（病院薬局、小売薬局、オンライン薬局、その他）、主要地域別市場規模（北米、アメ...

世界のデシタビン薬市場規模・現状・予測（2021年-2027年）

Global Decitabine Drug Market Size, Status and Forecast 2021-2027
QFJ1-5691 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、デシタビン薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ダコゲン、ジェネリック）、用途別市場規模（病院、ドラックストア）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド...

世界のメニエール病治療薬パイプライン市場規模・現状・予測（2021年-2027年）

Global Meniere Disease Drug Pipeline Market Size, Status and Forecast 2021-2027
QFJ1-4490 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、メニエール病治療薬パイプラインの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（めまい、耳分泌物、その他）、用途別市場規模（病院・クリニック、専門センター）、主要地域別市場規模（北米、アメリカ、欧州、ア...

世界の抗コリン薬市場規模・現状・予測（2021年-2027年） Anticholinergic drugs are used to restrict the acetylcholine-provoked neurotransmission in different parts of the body including heart, peripheral nervous system, and other parts. Acetylcholine controls the involuntary functions such as salivation, sweating, digestion, and several others. The drug i…
世界のノイラミニダーゼ阻害薬市場規模・現状・予測（2021年-2027年） Neuraminidase Inhibitors (NAIs) are the type of drugs that are used to block the neuraminidase enzyme. Market Analysis and Insights: Global Neuraminidase Inhibitors Drug Market The global Neuraminidase Inhibitors Drug market size is projected to reach US$ XX million by 2027, from US$ XX million in 2…
世界の急性肝性ポルフィリン症用医薬品市場規模・現状・予測（2021年-2027年） Acute hepatic porphyria drugs are used for the treatment of adult patients with acute hepatic porphyria. Market Analysis and Insights: Global Acute Hepatic Porphyria Drug Market The global Acute Hepatic Porphyria Drug market size is projected to reach US$ XX million by 2027, from US$ XX million in 2…
世界の徐放性医薬品市場規模・現状・予測（2021年-2027年） Drug delivery systems are engineered technologies for controlled release of drugs or to the targeted delivery of drugs. Drug delivery system is a kind of formulation that enables the administration of therapeutic agents in the body and improves its safety and efficacy by controlling the time, rate a…
世界の猫アトピー性皮膚炎薬市場規模・現状・予測（2021年-2027年） Feline atopic dermatitis is the inflammation of the skin seen in the cats. Feline atopic dermatitis is often triggered by causative allergens which are either inhaled or through skin contact leading to inflammation of the skin. Market Analysis and Insights: Global Feline Atopic Dermatitis Drug Marke…